Literature DB >> 22553749

Auto-cortex of crystalline lens-induced iris neovascularization.

Lin Liu1, Yong-Ping Li, Bo Zhang, Wen-Xin Zhang.   

Abstract

AIM: To investigate auto-cortex of crystalline lens induced iris neovascularization (INV).
METHODS: Thirty-six eyes of 36 guinea-pigs were included and divided into three groups randomly in this cohort study. Group A: the right lens nucleus was extracted and the remaining cortical lens material was aspirated thoroughly. Group B: the lens was removed and 30µL precipitated lens cortex was injected into the anterior chamber again. Group C: aspirated the lens cortex of the left eyes and inject them into the right anterior chambers about 10µL. Clinical changes were followed by slit-lamp examination and photograph. The eye balls were enucleated at the day of 2, 4, 7, 11, 13, 17 after operation. HE was used to detect the pathological changes. GROUP A: INV had not been observed until the end of empirical study. The stromal layer contained thick wall vessels, without expansion. Group B: All eyes developed INV. Postoperative (po) 7 days; the eyes developed intense and extensive INV. The vessels of iris expanded remarkably and neovascularization was observed erupting from it's lateral wall and stretching towards the anterior surface. Po11 days, INV regressed gradually after lens cortex had been absorbed. Group C: Po four (4) days, new blood vessels liking red line were presented on the anterior surface of the iris and they were not obvious.
CONCLUSION: Anterior chamber inside lens coriaceous can induce iris new blood vessels.

Entities:  

Keywords:  crystallins; iris; new vessels

Year:  2012        PMID: 22553749      PMCID: PMC3340841          DOI: 10.3980/j.issn.2222-3959.2012.01.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  11 in total

Review 1.  Neovascularization of the iris (rubeosis iridis).

Authors:  S Gartner; P Henkind
Journal:  Surv Ophthalmol       Date:  1978 Mar-Apr       Impact factor: 6.048

2.  Differences in the composition of inflammatory cell infiltrate in lens-induced uveitis under therapy with allopurinol or steroids.

Authors:  W Sekundo; A J Augustin
Journal:  Eur J Ophthalmol       Date:  2001 Jul-Sep       Impact factor: 2.597

3.  Neovascularization of the iris: an experimental model in cats.

Authors:  E Stefansson; M B Landers; M L Wolbarsht; G K Klintworth
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-03       Impact factor: 4.799

4.  [The progress in the prevention of blindness in China].

Authors:  Jia-liang Zhao
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2005-08

5.  Long-term complications after phacoemulsification for cataract removal in dogs: 172 cases (1995-2002).

Authors:  Kelly J Sigle; Mark P Nasisse
Journal:  J Am Vet Med Assoc       Date:  2006-01-01       Impact factor: 1.936

6.  Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.

Authors:  D Husain; J W Miller; A G Kenney; N Michaud; T J Flotte; E S Gragoudas
Journal:  Ophthalmology       Date:  1997-08       Impact factor: 12.079

7.  Dilation of the minor arterial circle of the iris preceding rubeosis iridis during retinal vein occlusion.

Authors:  Michel Paques; Jean-François Girmens; Eva Rivière; José Sahel
Journal:  Am J Ophthalmol       Date:  2004-12       Impact factor: 5.258

8.  Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.

Authors:  Naoyasu Umeda; Hiroaki Ozaki; Hideyuki Hayashi; Hiroyuki Kondo; Hiroko Uchida; Kenji Oshima
Journal:  Ophthalmic Res       Date:  2002 Jan-Feb       Impact factor: 2.892

9.  Experimental immunogenic rubeosis iridis.

Authors:  A L Shabo; D S Maxwell; P Shintaku; A E Kreiger; B R Straatsma
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-04       Impact factor: 4.799

10.  Hematoporphyrin photoradiation therapy for iris neovascularization. A preliminary report.

Authors:  A J Packer; D T Tse; X Q Gu; S S Hayreh
Journal:  Arch Ophthalmol       Date:  1984-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.